Skip to main content
Thorax logoLink to Thorax
. 1981 Apr;36(4):308–312. doi: 10.1136/thx.36.4.308

Ketotifen in atopic asthma and exercise-induced asthma.

I S Petheram, J Moxham, C W Bierman, M McAllen, S G Spiro
PMCID: PMC471498  PMID: 6116296

Abstract

The efficacy of ketotifen, a tricyclic benzocycloheptathiophene derivative, was assessed in an outpatient clinical trial and in a group of 12 asthmatic subjects with exercise-induced asthma. Subjects in the outpatient trial had mild asthma and consisted of two groups: a group of 24 atopic asthmatics with at least one positive skin test reaction and with an associated history of bronchial reactivity to at least one allergen; and a group of eight asthmatics with one or more positive skin prick tests but not bronchial reactivity to an allergen. Both groups took four weeks medication of ketotifen 1 mg bd and placebo in a randomised double-blind crossover study. There was no difference between ketotifen and placebo for any measurement made during the study and consequently no evidence of drug efficacy. The exercise study followed a standardised protocol and each subject took in random double-blind order, placebo, 1 mg, 2 mg, and 4 mg ketotifen two hours before exercise. There was no difference in the mean decreases in lung function from pre-exercise baseline values after three doses of ketotifen than with placebo. Drug levels suggested ketotifen was well absorbed. It would appear that if given for a period of only four weeks ketotifen had no beneficial effects in the management of mild asthma, and that a single dose before exercise does not modify exercise-induced asthma.

Full text

PDF
308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craps L., Greenwood C., Radielovic P. Clinical investigation of agents with prophylactic anti-allergic effects in bronchial asthma. Clin Allergy. 1978 Jul;8(4):373–382. doi: 10.1111/j.1365-2222.1978.tb00472.x. [DOI] [PubMed] [Google Scholar]
  2. Davies S. E. Effect of disodium cromoglycate on exercise-induced asthma. Br Med J. 1968 Sep 7;3(5618):593–594. doi: 10.1136/bmj.3.5618.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dyson A. J., Mackay A. D. Ketotifen in adult asthma. Br Med J. 1980 Feb 9;280(6211):360–361. doi: 10.1136/bmj.280.6211.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eggleston P. A., Guerrant J. L. A standardized method of evaluating exercise-induced asthma. J Allergy Clin Immunol. 1976 Sep;58(3):414–425. doi: 10.1016/0091-6749(76)90122-6. [DOI] [PubMed] [Google Scholar]
  5. Martin U., Roemer D. Ketotifen: a histamine release inhibitor. Monogr Allergy. 1977;12:145–149. [PubMed] [Google Scholar]
  6. Martin U., Römer D. The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene. Arzneimittelforschung. 1978;28(5):770–782. [PubMed] [Google Scholar]
  7. Mattson K., Poppius H., Nikander-Hurme R. Preventive effect of ketotifen, a new antiallergic agent, on histamine-induced bronchoconstriction in asthmatics. Clin Allergy. 1979 Jul;9(4):411–416. doi: 10.1111/j.1365-2222.1979.tb02500.x. [DOI] [PubMed] [Google Scholar]
  8. McFadden E. R., Jr, Ingram R. H., Jr Exercise-induced asthma: Observations on the initiating stimulus. N Engl J Med. 1979 Oct 4;301(14):763–769. doi: 10.1056/NEJM197910043011406. [DOI] [PubMed] [Google Scholar]
  9. Taylor B., Ford R. Ketotifen in childhood asthma: a double-blind placebo controlled trial. Clin Allergy. 1979 May;9(3):241–243. doi: 10.1111/j.1365-2222.1979.tb01549.x. [DOI] [PubMed] [Google Scholar]
  10. Wüthrich B. Protective effect of ketotifen and disodium cromoglycate against bronchoconstriction induced by aspirin, benzoic acid or tartrazine in intolerant asthmatics. Respiration. 1979;37(4):224–231. doi: 10.1159/000194032. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES